DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Pluristem Therapeutics, Inc. (PSTI)
« Back to company indexPSTI Chatter Timeline
Stock Ticker for PSTI
Most Active Tweeters for PSTI
| User | Tweets |
|---|---|
| @GantosJ | 8 |
| @dakotafinancial | 3 |
| @macondailynews | 2 |
| @StunningFeline | 2 |
| @phatoftheland10 | 1 |
Recent Tweets for PSTI
 |
@outsider_alerts $PSTI - PRICE x VOLUME ALERT - Price: 3.96, up 10.0% over prior 10 minute average, Volume: off the dang charts October 21st 2019, 3:10pm |
 |
@StunningFeline RT @GantosJ: With lack of suitable non-surgical therapeutic options for the growing population of CLI patients $PSTI cell-therapy demonstra… October 21st 2019, 3:10pm |
 |
@greyzone513 RT @GantosJ: The $PSTI Cell-Therapy saved this #CLI 77 years old patient's leg from certain imputation as gangrene spread due #diabetes & 1… October 21st 2019, 3:10pm |
 |
@TimeWipe Possible breakout on $PSTI October 21st 2019, 2:10pm |
 |
@SwingTradeBot Rose Above 50 DMA today: $PSTI ... https://t.co/qwiJH6vr1O October 21st 2019, 1:10pm |
 |
@GantosJ With lack of suitable non-surgical therapeutic options for the growing population of CLI patients $PSTI cell-therap… https://t.co/9PfRlh4lop October 21st 2019, 11:10am |
|
@GantosJ RT @StunningFeline: $PSTI treatment for CLI is a game changer. Listen to the Dr talk about how she could hear a pulse prior to treatment an… October 21st 2019, 10:10am |
|
@GantosJ RT @phatoftheland10: Say NO to amputation. #CLIFighters #StopCLI $psti #diabetes #DiabetesAwareness https://t.co/pWXNPdyd9g October 21st 2019, 10:10am |
 |
@phatoftheland10 Say NO to amputation. #CLIFighters #StopCLI $psti #diabetes #DiabetesAwareness https://t.co/pWXNPdyd9g October 21st 2019, 10:10am |
|
@GantosJ @StunningFeline True, despite the fact that this $PSTI Ph3 trial is double blinded & placebo controlled... but as D… https://t.co/ZA4woZfotj October 21st 2019, 9:10am |
 |
@dakotafinancial Pluristem Therapeutics $PSTI Rating Increased to Buy at Zacks Investment Research https://t.co/yZT8fy09Rz October 21st 2019, 9:10am |
|
@GantosJ @StunningFeline That's the best proof that $PSTI cell-therapy is the reason the #CLI patient grow new blood vessels… https://t.co/E0iBh3HpKg October 21st 2019, 9:10am |
|
@StunningFeline $PSTI treatment for CLI is a game changer. Listen to the Dr talk about how she could hear a pulse prior to treatmen… https://t.co/wiZjN3FaTW October 21st 2019, 9:10am |
|
@GantosJ $PSTI PLX-PAD cells can grow more arteries to restore blood flow to his legs so the wounds on his toes would heal.… https://t.co/SDjN8WniMp October 21st 2019, 8:10am |
|
@GantosJ The $PSTI Cell-Therapy saved this #CLI 77 years old patient's leg from certain imputation as gangrene spread due… https://t.co/OEvBRT5Bq9 October 21st 2019, 8:10am |
 |
@TheMarketsDaily Pluristem Therapeutics $PSTI Upgraded to “Buy” at Zacks Investment Research https://t.co/euAkBSsYqd October 19th 2019, 1:10pm |
 |
@macondailynews Zacks Investment Research Upgrades Pluristem Therapeutics $PSTI to “Buy” https://t.co/e9cqzXrM8o October 19th 2019, 1:10pm |
|
@dakotafinancial Pluristem Therapeutics $PSTI Stock Price Crosses Above 200-Day Moving Average of $2.05 https://t.co/xpf9Z30kjs October 18th 2019, 5:10am |
 |
@ZolmaxNews Pluristem Therapeutics $PSTI Raised to Buy at Zacks Investment Research https://t.co/xsMoq0t2hv October 17th 2019, 10:10am |
 |
@bbnsnews Pluristem Therapeutics $PSTI Stock Price Passes Above 200 Day Moving Average of $2.05 https://t.co/QSsP9ucL3C October 16th 2019, 5:10pm |
 |
@ConsumerFeed Pluristem Therapeutics $PSTI Shares Pass Above 200 Day Moving Average of $2.05 https://t.co/h2EePiptaX October 16th 2019, 5:10pm |
|
@macondailynews Pluristem Therapeutics Inc. $PSTI Expected to Announce Earnings of -$0.80 Per Share https://t.co/dZm6pz96gC October 12th 2019, 5:10pm |
|
@dakotafinancial Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/ADwpkPMU9H October 9th 2019, 11:10pm |
 |
@AmericanBanking Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/qRvFyk3Vn0 #stocks October 9th 2019, 11:10pm |
|
@GantosJ $PSTI Pluristem Therapeutics Inc. Insiders Increased Their Holdings https://t.co/Cmfidl6p5f October 9th 2019, 11:10am |
 |
@stocknewstimes Pluristem Therapeutics $PSTI Share Price Passes Above Two Hundred Day Moving Average of $1.90 https://t.co/xsx9yXP08K October 7th 2019, 10:10pm |
 |
@TranscriptDaily Pluristem Therapeutics $PSTI Shares Pass Above 200 Day Moving Average of $1.90 https://t.co/kBQcMyvvxj October 7th 2019, 10:10pm |
 |
@scriptstotrade $PSTI $SES Do you have all the tools you need to start your week? Here is our REVERSE SPLIT scanner with earnings… https://t.co/Kkt2iWYEAl September 30th 2019, 6:09pm |
 |
@OlympiaReport Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/BEQW69V4SR September 29th 2019, 11:09pm |
 |
@dispatchtribune Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/tQNwM8dLGm September 29th 2019, 11:09pm |
 |
@TickerReport Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/Zn14Ags62s September 28th 2019, 8:09am |
|
@ZolmaxNews Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/nAEoTDMLZi September 28th 2019, 8:09am |
|
@AmericanBanking Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/PxxfrGOvQM #stocks September 28th 2019, 8:09am |
 |
@WatchlistN Pluristem Therapeutics Inc. $PSTI Short Interest Up 9.0% in September https://t.co/vNrIVI2N6j September 28th 2019, 8:09am |
 |
@ThisLincolnian Pluristem Therapeutics $PSTI Stock Price Passes Above 200 Day Moving Average of $1.75 https://t.co/1cyKtVZSiQ September 24th 2019, 7:09pm |
 |
@WeekHerald Pluristem Therapeutics $PSTI Share Price Passes Above 200 Day Moving Average of $1.75 https://t.co/d8OLO68uu8 September 24th 2019, 7:09pm |
 |
@scientwest RT @GantosJ: $PSTI have the cell-therapy to treat #PAD #CLI US study: 30% of black men and women were estimated to develop PAD during thei… September 24th 2019, 10:09am |
|
@GantosJ $PSTI have the cell-therapy to treat #PAD #CLI US study: 30% of black men and women were estimated to develop PAD… https://t.co/ut54c6I9oZ September 24th 2019, 8:09am |
|
@TranscriptDaily Zacks: Analysts Expect Pluristem Therapeutics Inc. $PSTI to Post -$0.70 EPS https://t.co/eW2URRo5qn September 22nd 2019, 10:09pm |
|
@stocknewstimes Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/qYzIIe3toR September 22nd 2019, 10:09pm |
 |
@SleekMoneycom Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/ypWJkzc4NU #investing September 22nd 2019, 10:09pm |
 |
@storminvestor Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Post Earnings of -$0.70 Per Share https://t.co/PqneomTM1s #markets September 22nd 2019, 10:09pm |
|
@GantosJ @semodough Good $PSTI summary by Ladenburg analyst, but he's missing the point of the #CLI European submission post… https://t.co/PhWHlh8GUS September 17th 2019, 2:09pm |
 |
@semodough $PSTI catalysts lead clinical program, PLX-PAD for muscle regeneration after hip fracture surgery is in Phase 3 dev… https://t.co/SE0Zpsoyan September 17th 2019, 1:09pm |
 |
@Gambiste1 RT @GantosJ: $PSTI Recaps KOL Call Hematological Programs Data from 1st & 2nd cohorts of hematological study showed PLX-R18 was safe & wel… September 17th 2019, 9:09am |
 |
@OpenOutcrier $PSTI (+3.9% pre) Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs - SI https://t.co/D4BnZR2gsK September 17th 2019, 8:09am |
 |
@IncredibleTrade H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Pluristem Therapeutics (NASDAQ: $PSTI) to… https://t.co/VsZLCI2SW1 September 17th 2019, 7:09am |
|
@IncredibleTrade Ladenburg Thalmann analyst Matthew Kaplan raised the price target on Pluristem Therapeutics (NASDAQ: $PSTI) to $25.… https://t.co/R9IJnzKPvl September 17th 2019, 6:09am |
|
@AmericanBanking Brokerages Expect Pluristem Therapeutics Inc. $PSTI to Announce -$0.70 EPS https://t.co/bVDXIuU0Pl #stocks September 17th 2019, 4:09am |
 |
@LifeSciAdvisors Pluristem Therapeutics $PSTI Recaps Key Opinion Leader Call Reviewing Hematological Programs https://t.co/wIsIAJECSW September 16th 2019, 6:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.